These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 29913478)
1. Lipid Biomarkers in Acute Myocardial Infarction Before and After Percutaneous Coronary Intervention by Lipidomics Analysis. Feng L; Yang J; Liu W; Wang Q; Wang H; Shi L; Fu L; Xu Q; Wang B; Li T Med Sci Monit; 2018 Jun; 24():4175-4182. PubMed ID: 29913478 [TBL] [Abstract][Full Text] [Related]
2. Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction. Hortmann M; Robinson S; Mohr M; Haenel D; Mauler M; Stallmann D; Reinoehl J; Duerschmied D; Peter K; Bode C; Ahrens I Int J Cardiol; 2017 Sep; 243():485-491. PubMed ID: 28602551 [TBL] [Abstract][Full Text] [Related]
3. Apoptosis kinetics at reperfusion period in patients with acute ST-Segment Elevation Myocardial Infarction undergoing primary percutaneous coronary intervention and treated with thrombolytic therapy. Gultekin N; Bulut G; Kucukates E; Yildiz A; Kocas C; Bulut L J Pak Med Assoc; 2016 Jul; 66(7):808-14. PubMed ID: 27427127 [TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide as a predictor of ischemia/reperfusion injury immediately after myocardial reperfusion in patients with ST-segment elevation acute myocardial infarction. Arakawa K; Himeno H; Kirigaya J; Otomo F; Matsushita K; Nakahashi H; Shimizu S; Nitta M; Takamizawa T; Yano H; Endo M; Kanna M; Kimura K; Umemura S Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):62-70. PubMed ID: 25609593 [TBL] [Abstract][Full Text] [Related]
5. Metabolomic characterization of myocardial ischemia-reperfusion injury in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. Surendran A; Aliani M; Ravandi A Sci Rep; 2019 Aug; 9(1):11742. PubMed ID: 31409856 [TBL] [Abstract][Full Text] [Related]
6. Metabolomic Profiling in Acute ST-Segment-Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia-Reperfusion Injury. Kohlhauer M; Dawkins S; Costa ASH; Lee R; Young T; Pell VR; Choudhury RP; Banning AP; Kharbanda RK; ; Saeb-Parsy K; Murphy MP; Frezza C; Krieg T; Channon KM J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29626151 [TBL] [Abstract][Full Text] [Related]
7. Impact of multivessel coronary artery disease on reperfusion success in patients with ST-elevation myocardial infarction: A substudy of the AIDA STEMI trial. de Waha S; Eitel I; Desch S; Fuernau G; Pöss J; Schuler G; Thiele H Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):592-600. PubMed ID: 26691729 [TBL] [Abstract][Full Text] [Related]
8. The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction. Hortmann M; Robinson S; Mohr M; Mauler M; Stallmann D; Reinöhl J; Duerschmied D; Peter K; Carr J; Gibson CM; Bode C; Ahrens I Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):695-702. PubMed ID: 28534645 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal extent of lipid pool assessed by optical coherence tomography predicts microvascular no-reflow after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Ikenaga H; Ishihara M; Inoue I; Kawagoe T; Shimatani Y; Miura F; Nakama Y; Dai K; Ohtani T; Ohi K; Miki T; Nakamura M; Kishimoto S; Sumimoto Y; Kihara Y J Cardiol; 2013 Aug; 62(2):71-6. PubMed ID: 23680004 [TBL] [Abstract][Full Text] [Related]
10. Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction. Chen WR; Chen YD; Tian F; Yang N; Cheng LQ; Hu SY; Wang J; Yang JJ; Wang SF; Gu XF Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940956 [TBL] [Abstract][Full Text] [Related]
11. The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry. Peiyuan H; Jingang Y; Haiyan X; Xiaojin G; Ying X; Yuan W; Wei L; Yang W; Xinran T; Ruohua Y; Chen J; Lei S; Xuan Z; Rui F; Yunqing Y; Qiuting D; Hui S; Xinxin Y; Runlin G; Yuejin Y; PLoS One; 2016; 11(11):e0165672. PubMed ID: 27812152 [TBL] [Abstract][Full Text] [Related]
12. Reperfusion in STEMI patients: still a role for cardioprotection? Ottani F; Limbruno U; Latini R; Misuraca L; Galvani M Minerva Cardioangiol; 2018 Aug; 66(4):452-463. PubMed ID: 29589674 [TBL] [Abstract][Full Text] [Related]
13. Effect of Hematologic Parameters on Microvascular Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. Karahan Z; Uçaman B; Uluğ AV; Aydınalp Ö; Uğurlu M; Çevik K; Kaya İ; Öztürk Ö Angiology; 2016 Feb; 67(2):151-6. PubMed ID: 26007233 [TBL] [Abstract][Full Text] [Related]
14. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966 [TBL] [Abstract][Full Text] [Related]
15. Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Capranzano P; Capodanno D; Bucciarelli-Ducci C; Gargiulo G; Tamburino C; Francaviglia B; Ohno Y; La Manna A; Antonella S; Attizzani GF; Angiolillo DJ; Tamburino C Eur Heart J Acute Cardiovasc Care; 2016 Sep; 5(5):475-86. PubMed ID: 26758542 [TBL] [Abstract][Full Text] [Related]
16. The effects of remote ischemic conditioning in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a meta-analysis. Gao J; Chen Q; Liu F; Zhao Q; Chen B; Zhou Y; Zhao Q; Ma Y; Yang Y Minerva Med; 2017 Aug; 108(4):370-380. PubMed ID: 28217986 [TBL] [Abstract][Full Text] [Related]
17. Impact of postconditioning with lactate-enriched blood on in-hospital outcomes of patients with ST-segment elevation myocardial infarction. Koyama T; Munakata M; Akima T; Kageyama T; Shibata M; Moritani K; Kanki H; Ishikawa S; Mitamura H Int J Cardiol; 2016 Oct; 220():146-8. PubMed ID: 27379916 [TBL] [Abstract][Full Text] [Related]
18. High-sensitivity C-reactive protein and long term reperfusion success of primary percutaneous intervention in ST-elevation myocardial infarction. Groot HE; Karper JC; Lipsic E; van Veldhuisen DJ; van der Horst ICC; van der Harst P Int J Cardiol; 2017 Dec; 248():51-56. PubMed ID: 28826799 [TBL] [Abstract][Full Text] [Related]
19. Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings. Campo G; Morciano G; Pavasini R; Bonora M; Sbano L; Biscaglia S; Bovolenta M; Pinotti M; Punzetti S; Rizzo P; Aquila G; Giorgi C; Ferrari R; Pinton P Int J Cardiol; 2016 Oct; 221():993-7. PubMed ID: 27441480 [TBL] [Abstract][Full Text] [Related]
20. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome. Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]